Evidence map›Paper›PMID 20689519›Full record

ArticleAmerican journal of hypertension2010

The counter-regulatory effects of ESE-1 during angiotensin II-mediated vascular inflammation and remodeling.

Yumei Zhan, Lei Yuan, Maiko Kondo, Peter Oettgen

Open access · bronzeAbstract read
In one paragraph

Article in American journal of hypertension, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yumei ZhanDivision of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Lei Yuan
Maiko Kondo
Peter Oettgen
Beth Israel Deaconess Medical Center · USCenter for Vascular Biology Research · US

Funding

The Role of Ets-1 in Vascular InflammationR01HL082717 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI OETTGEN, J PETER PETER · 2008 to 2011
$1.7M
Regulation of Vascular Inflammation by ESE-1R01HL067219 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI OETTGEN, J PETER PETER · 2001 to 2004
$1.4M
NHLBI NIH HHS R01 HL067219NHLBI NIH HHS R01 HL082717NHLBI NIH HHS R01-HL-67219NHLBI NIH HHS R01-HL-82717
6 · The paper itself

Abstract

backgroundAngiotensin II (Ang II) is a critical mediator vascular inflammation and remodeling in a number of diseases including hypertension and atherosclerosis. The purpose of this study was to evaluate the role of the epithelium-specific ETS transcription factor-1 (ESE-1), a member of E26 transformation-specific sequence (ETS) transcription factors, as a mediator of Ang II-mediated vascular responses.

methodsESE-1 knockout mice were used to evaluate the role of ESE-1 in regulating Ang II-mediated vascular inflammation and remodeling.

resultsESE-1 levels are low to undetectable under basal conditions but rapidly increase in response to Ang II. Intimal medial thickness and perivascular fibrosis of the aorta were significantly greater in ESE-1 knockout mice compared with the wild-type littermate controls. Proliferating cell nuclear antigen (PCNA) staining was also greater in the aorta of the Ang II-infused ESE-1 knockout mice compared with the controls. The infiltration of T cells and macrophage into the vessel wall of the aorta was dramatically enhanced in the ESE-1 knockout mice compared with the controls. Finally, Ang II-induced expression of a known downstream target of ESE-1, nitric oxide synthase 2 (NOS2), was significantly blunted in ESE-1 knockout mice compared to littermate controls. The alterations in vascular inflammation and remodeling were associated with an exaggerated systolic blood pressure response to Ang II in ESE-1 knockout mice.

conclusionsESE-1 is an Ang II-inducible transcription factor that plays an important counter-regulatory role in the setting of vascular inflammation and remodeling.

Indexed as

Angiotensin IIAnimalsAortaDNA-Binding ProteinsEndothelium, VascularHumansHypertensionMaleMiceMice, KnockoutNitric Oxide Synthase Type IITranscription FactorsVasculitisAngiotensin IIDNA-Binding ProteinsElf3 protein, mouseNitric Oxide Synthase Type IINos2 protein, mouseTranscription Factors

Identifiers

PMID20689519
PMCPMC3715883
OpenAlexW2329383614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.